To test whether disrupting CLEC14A and CD93 interactions had an effect on tumour growth in vivo, the mouse MMRN2495–678 fragment and the mouse CLEC14A-ECD were fused to a mouse IgG Fc tag. The gene discussed is CLEC14A; the disease is neoplasm.